Literature DB >> 4065299

Arousal deficit shown in aged rat's quantitative EEG and ameliorative action of pramiracetam compared to piracetam.

B P Poschel, P M Ho, F W Ninteman.   

Abstract

The basal EEG profile of the aged Fisher-344 rat was consistently different from that of the young rat, showing dominant high voltage slow-wave components. These slow waves were present in both the frontal cerebral cortex and dorsal hippocampus. Absent or greatly attenuated in the aged rat's hippocampal EEG was rhythmic theta activity, which was always dominant in the young awake rat's hippocampus. These EEG differences were clearly apparent only under basal test conditions, i.e., following habituation to the test situation. Pramiracetam sulfate acted strongly to normalize the aged rat's EEG, while the action of piracetam was weak and appeared to undergo tolerance development.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4065299     DOI: 10.1007/BF01950020

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  3 in total

1.  [Piracetam and vigilance. A study of EEG changes and clinical effects in gerontopsychiatric patients (author's transl)].

Authors:  D Bente; G Glatthaar; G Ulrich; M Lewinsky
Journal:  Arzneimittelforschung       Date:  1978

2.  Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.

Authors:  D E Butler; I C Nordin; Y J L'Italien; L Zweisler; P H Poschel; J G Marriott
Journal:  J Med Chem       Date:  1984-05       Impact factor: 7.446

3.  Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver.

Authors:  B Saletu; J Grünberger; L Linzmayer
Journal:  Methods Find Exp Clin Pharmacol       Date:  1980-10
  3 in total
  1 in total

1.  Temporal evolution of neurophysiological and behavioral features of synapsin I/II/III triple knock-out mice.

Authors:  Marco Cambiaghi; Marco Cursi; Elena Monzani; Fabio Benfenati; Giancarlo Comi; Fabio Minicucci; Flavia Valtorta; Letizia Leocani
Journal:  Epilepsy Res       Date:  2012-07-28       Impact factor: 3.045

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.